Cargando…

157: C-reactive protein (CRP) as a biomarker of exacerbation presentation and treatment response

Detalles Bibliográficos
Autores principales: VanDevanter, D., Heltshe, S., Skalland, M., West, N., Sanders, D., Goss, C., Flume, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Cystic Fibrosis Society. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518450/
http://dx.doi.org/10.1016/S1569-1993(21)01582-4
_version_ 1784584226177286144
author VanDevanter, D.
Heltshe, S.
Skalland, M.
West, N.
Sanders, D.
Goss, C.
Flume, P.
author_facet VanDevanter, D.
Heltshe, S.
Skalland, M.
West, N.
Sanders, D.
Goss, C.
Flume, P.
author_sort VanDevanter, D.
collection PubMed
description
format Online
Article
Text
id pubmed-8518450
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Cystic Fibrosis Society.
record_format MEDLINE/PubMed
spelling pubmed-85184502021-10-15 157: C-reactive protein (CRP) as a biomarker of exacerbation presentation and treatment response VanDevanter, D. Heltshe, S. Skalland, M. West, N. Sanders, D. Goss, C. Flume, P. J Cyst Fibros Posters European Cystic Fibrosis Society. 2021-11 2021-10-15 /pmc/articles/PMC8518450/ http://dx.doi.org/10.1016/S1569-1993(21)01582-4 Text en Copyright © 2021 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Posters
VanDevanter, D.
Heltshe, S.
Skalland, M.
West, N.
Sanders, D.
Goss, C.
Flume, P.
157: C-reactive protein (CRP) as a biomarker of exacerbation presentation and treatment response
title 157: C-reactive protein (CRP) as a biomarker of exacerbation presentation and treatment response
title_full 157: C-reactive protein (CRP) as a biomarker of exacerbation presentation and treatment response
title_fullStr 157: C-reactive protein (CRP) as a biomarker of exacerbation presentation and treatment response
title_full_unstemmed 157: C-reactive protein (CRP) as a biomarker of exacerbation presentation and treatment response
title_short 157: C-reactive protein (CRP) as a biomarker of exacerbation presentation and treatment response
title_sort 157: c-reactive protein (crp) as a biomarker of exacerbation presentation and treatment response
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518450/
http://dx.doi.org/10.1016/S1569-1993(21)01582-4
work_keys_str_mv AT vandevanterd 157creactiveproteincrpasabiomarkerofexacerbationpresentationandtreatmentresponse
AT heltshes 157creactiveproteincrpasabiomarkerofexacerbationpresentationandtreatmentresponse
AT skallandm 157creactiveproteincrpasabiomarkerofexacerbationpresentationandtreatmentresponse
AT westn 157creactiveproteincrpasabiomarkerofexacerbationpresentationandtreatmentresponse
AT sandersd 157creactiveproteincrpasabiomarkerofexacerbationpresentationandtreatmentresponse
AT gossc 157creactiveproteincrpasabiomarkerofexacerbationpresentationandtreatmentresponse
AT flumep 157creactiveproteincrpasabiomarkerofexacerbationpresentationandtreatmentresponse